Log In
BCIQ
Print this Print this
 

EV06

  Manage Alerts
Collapse Summary General Information
Company Encore Vision Inc.
Description1.5% lipoic acid choline ester, which breaks down into lipoic acid and choline
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationPresbyopia
Indication DetailsTreat presbyopia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/20/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today